NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Science Letter

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Science Letter

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Alzheimer Disease



Researchers detail new studies and findings in the area of Alzheimer disease



July 12th, 2005

Alzheimer disease data are the focus of recent research from Switzerland, Japan and Sweden.

Study 1: Beta-site specific intrabodies prevents generation of Alzheimer's A beta peptide.

According to a recent report published in the Journal of Cell Biology, "Endoproteolysis of the beta-amyloid precursor protein (APP) by beta- and gamma-secretases generates the toxic amyloid beta-peptide (A beta), which accumulates in the brain of Alzheimer's disease (AD) patients.

"Here, we established a novel approach to regulate production of A beta based on intracellular expression of single chain antibodies (intrabodies) raised to an...


Source: Science Letter (2005-07-12)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login